Abstract:Background: MicroRNAs (miRNAs), small non-coding, cellular RNAs (17-27 bp) that post-transcriptionally regulate gene expression by inducing the degradation or translational repression of target mRNAs, function as oncogenes and tumor suppressors via binding target genes. Their expression levels are associated with a variety of cancers. This study to explore the miRNA expression differences between pancreatic cancer tissue and adjacent tissue, and their impact on the biological characteristics of pancreatic cancer cells. Lay the foundation for further study of the molecular mechanisms of miRNAs in pancreatic cancer development.Methods: Differential expression of 13 miRNAs (miR-9, miR-21, miR-103, miR-106a, miR-139, miR-143, miR-145, miR-185, miR-195, miR-221, miR-222, miR-381, miR-638) was analyzed by real time RT-PCR. All 13 miRNAs chosen for the test are based on their potential functions related to cancer biology, cell development and apoptosis. The expression of miRNAs for pancreatic cancer tissue samples was normalized to U6 RNA and compared with those in the relatively para-carcinoma tissue. MiRNA-106a mimics and inhibitors were transfected in Panc-01 using Lipofectamine 2000. The rate of cell proliferation and apoptosis changes were detected with MTT and flow cytometry respectively.Results: The results show miRNA-21/106a/222 were up-regulated in pancreatic cancer. MiRNA-21 was up-regulated in 85.71% patients by an average of 42.01 times. MiRNA-106a was up-regulated in 90.47% patients by an average of 4.44 times, MiRNA-222 was 76.19% and 6.81. Cells transfected with miR-106a inhibitor proliferated at a significantly lower rate than the mimics group as evaluated by MTT assay. By Annexin V analysis, the apoptotic cells were significantly increased in cells transfected with miR-106a inhibitor as compared to cells transfected with mimics.Conclusion: Pancreatic cancer has a miRNA-specific expression profile. The miRNAs were differentially expressed between pancreatic cancer tissue and adjacent tissue. MiRNA-106a was highly expressed in pancreatic cancer, indicated it has positive aspect in occurrence and development of pancreatic cancer. The treatment of inhibiting miRNA-106a may be a efficient approach to treat pancreatic cancer. Background: MicroRNAs (miRNAs), small non-coding, cellular RNAs (17-27 bp) that post-transcriptionally regulate gene expression by inducing the degradation or translational repression of target mRNAs, function as oncogenes and tumor suppressors via binding target genes. Their expression levels are associated with a variety of cancers. This study to explore the miRNA expression differences between pancreatic cancer tissue and adjacent tissue, and their impact on the biological characteristics of pancreatic cancer cells. Lay the foundation for further study of the molecular mechanisms of miRNAs in pancreatic cancer development. Methods: Differential expression of 13 miRNAs (miR-9, miR-21, miR-103, miR-106a, miR-139, miR-143, miR-145, miR-185, miR-195, miR-221, miR-222, miR-381, miR-638) was analyzed by real time RT-PCR. All 13 miRNAs chosen for the test are based on their potential functions related to cancer biology, cell development and apoptosis. The expression of miRNAs for pancreatic cancer tissue samples was normalized to U6 RNA and compared with those in the relatively para-carcinoma tissue. MiRNA-106a mimics and inhibitors were transfected in Panc-01 using Lipofectamine 2000. The rate of cell proliferation and apoptosis changes were detected with MTT and flow cytometry respectively. Results: The results show miRNA-21/106a/222 were up-regulated in pancreatic cancer. MiRNA-21 was up-regulated in 85.71% patients by an average of 42.01 times. MiRNA-106a was up-regulated in 90.47% patients by an average of 4.44 times, MiRNA-222 was 76.19% and 6.81. Cells transfected with miR-106a inhibitor proliferated at a significantly lower rate than the mimics group as evaluated by MTT assay. By Annexin V analysis, the apoptotic cells were significantly increased in cells transfected with miR-106a inhibitor as compared to cells transfected with mimics. Conclusion: Pancreatic cancer has a miRNA-specific expression profile. The miRNAs were differentially expressed between pancreatic cancer tissue and adjacent tissue. MiRNA-106a was highly expressed in pancreatic cancer, indicated it has positive aspect in occurrence and development of pancreatic cancer. The treatment of inhibiting miRNA-106a may be a efficient approach to treat pancreatic cancer.

Effect of Mir-548J-5p Expression on Invasion of Pancreatic Cancer

The Effects of Mirnas-107 on Cell Proliferation, Senescence and Invasion of Pancreatic Cancer PANC-1 Cells

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

Expression of microR-144-3p in pancreatic cancer and its effect on migration and invasion of pancreatic cancer cells

The Effects of Mirna-1180 on Suppression of Pancreatic Cancer.

The expression of miR-324-5p in pancreatic cancer and its effects and mechanisms on proliferation and migration of pancreatic cancer cells

Functional Study of Mirna-301A-3p in Pancreatic Cancer

Expression of microRNA-28-5p in serum and its effect on progression of pancreatic cancer

Mirna-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells

Effects of microRNA-138-5p on the migration and invasion of pancreatic cancer PANC-1 cells by targeting vimentin

Regulation of Mir-155 Affects Pancreatic Cancer Cell Invasiveness and Migration by Modulating the STAT3 Signaling Pathway Through SOCS1.

Expression and Effect of Mir-769-5p on Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

The Effect of miRNA-137 on Proliferation of Pancreatic Cancer Cell

The Exploration of Micrornas Expression Profiling in Pancreatic Cancer

[Expression of Mir-454-3p and Its Effect on Proliferation, Invasion and Metastasis of Colon Cancer].

Effect of Mir-548C-5p on Biological Behaviors of Breast Cancer Cell Line MCF-7

[The Expression of Long Non-Coding RNA-LINC01410 in Pancreatic Cancer and Its Effect on Proliferation and Migration of Pancreatic Cancer Cells].

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

[Role of Mir-155 in Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].

Mir-1181 Inhibits Invasion and Proliferation Via STAT3 in Pancreatic Cancer

Effects of Mir-339-5p on Invasion and Prognosis of Hepatocellular Carcinoma.